An Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of mRNA-3745 in Participants with Glycogen Storage Disease Type 1a (GSD1a)
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
August 19, 2022
End Date
December 31, 2024
Administered By
Pediatrics, Medical Genetics
Awarded By
Moderna Therapeutics, Inc.
Start Date
August 19, 2022
End Date
December 31, 2024